María José Calmuntia

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

Jesús F. San Miguel, María‐Belén Vídriales, C López-Berges et al. · Blood · 2001 · 332 citations · Full text

Medicine, Hematology, Oncology +16

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

Jesús F. San Miguel, Antônio Vaz de Macedo, María‐Belén Vídriales et al. · Blood · 1997 · 274 citations · Full text

Medicine, Hematology, Oncology +16

Bone remodelation markers are useful in the management of monoclonal gammopathies

José M. Hernández, Begoña Suquía, José Antonio Queizán et al. · The Hematology Journal · 2004 · 16 citations

Medicine, Orthopedic Surgery, Bone Metabolism +12

Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.

Carmen Chillón, Ramón García‐Sánz, Ana Balanzategui et al. · PubMed · 2001 · 15 citations

Medicine, Genetics, Hematology +17

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

Jesús F. San Miguel, Antônio Vaz de Macedo, María‐Belén Vídriales et al. · Blood · 1997 · 14 citations · Full text

Medicine, Hematology, Oncology +16